Indian Nutraceutical Industry: Problems, Regulation & the Future

Indian Nutraceutical Industry: Problems, Regulation & the Future

Due to the present epidemic and growing emphasis on general health, nutraceuticals are becoming more significant. Products that support immune maintenance and illness prevention are classified as nutraceuticals. Additionally, lifestyle-related problems are significantly influenced by poor diet. Numerous nutraceuticals have gained popularity due to their demonstrated medicinal potential. The two primary categories of nutraceuticals are functional foods and dietary supplements. The approval, marketing, and labeling requirements for health supplements and nutraceuticals are entirely within the jurisdiction of the Food Safety and Standards Authority of India (FSSAI).

The usage of nutraceuticals and its basis

Dietary components play a crucial role in the pathophysiology of both health and disease. Obesity, hypertension, and diabetes are just a few of the lifestyle-related conditions that are linked to diet. A person with poor nutritional status has weakened immunity, which leaves them vulnerable to a variety of illnesses. In developing nations like India, nutritional inadequacies are also prevalent, which has prompted the creation of national healthcare programs to address conditions including anemia, goiter, and blindness.

In our nation, iodine and iron deficiencies have long been addressed by fortifying table salt with iodine and wheat flour with folic acid. New methods of enhancing food have emerged as a result of scientific breakthroughs and creative technological advancements.

Current Challenges & Structural Problems

Despite robust growth statistics, the sector is grappling with deep-rooted structural issues.

1. Regulatory Ambiguity & Compliance Challenges

A persistent problem is regulatory confusion between food supplements and drugs:

• Regulators struggle to delineate nutraceuticals vs pharmaceuticals, causing uncertainty for product approvals. Ambiguous definitions on permissible ingredients, therapeutic claims, and clinical evidence create barriers.
• Novel ingredients require 15–30 years of prior safe use, significantly slowing innovation.

2. Quality & Consumer Trust Deficit

Quality concerns are not hypothetical. Independent testing revealed:

• At an accredited lab in Ahmedabad, 18% of tested nutritional supplements failed safety standards.

Other challenges include:

• Counterfeit or substandard products undermining consumer confidence.
• Unclear or misleading health claims on labels.

These concerns suppress repeat purchases and hamper long-term industry credibility.

3. Cost, Tax Burden & Market Access

High pricing due to:

• Elevated GST rates (18%–28%) on nutraceuticals compared to essential foods.
• Premium raw material costs (e.g., omega-3s, probiotics).

These pressures result in:

• Higher consumer prices, limiting penetration in rural and price-sensitive segments.
• Smaller firms struggling to scale against cost inefficiencies.

Regulatory Framework: Progress & Limitations

Food Safety and Standards Authority of India (FSSAI)

The FSSAI remains the primary regulator for nutraceuticals under the Food Safety and Standards Act.

Key regulatory strides include:

• Draft Nutraceuticals & Functional Foods Rules, 2023 to shorten approval timelines.
• Mandatory clear labeling of health claims starting 2024.
• Growing focus on scientific committees to establish standards.
• Government allocation of INR 500 crore (~USD 60M) for R&D in nutraceuticals.

Despite improvements, critics highlight:

• Lack of pre-market clinical evidence requirements.
• Fragmented interpretation across states.

This underscores the need for harmonised, globally consistent regulation.

Future Outlook: Growth, Innovation & Strategic Shifts

Even with challenges, multiple trends point towards sustained expansion:

1. Consumer Demand for Preventive Health

Increasing awareness of lifestyle diseases (diabetes, cardiovascular issues) is driving nutraceutical adoption for preventive care. The middle-class health spend is rising, bolstering market value.

2. Digital & Retail Expansion

E-commerce continues to expand distribution, particularly in urban and semi-urban markets. Digital retail can accelerate reach to health-conscious consumers, especially younger demographics.

3. Scientific & Personalized Nutrition

Post-pandemic trends show a move towards:

• Biomarker-driven, evidence-based formulations.
• AI, diagnostics, and wearable integration for personalised natural solutions.

These elevate nutraceuticals beyond generic wellness products into performance-optimized nutrition.

Expert Perspective & Opinion

Opinion (Evidence-Backed):

India’s nutraceutical industry sits at an innovation inflection point. Regulatory ambiguity and quality lapses are valid concerns, but they also represent opportunities for differentiation:

• Brands investing in clinical evidence and transparent labeling can build long-term consumer trust.
• Aligning with global standards (USFDA, EFSA) could unlock export markets.
• Strategic tax reforms and classification clarity will democratise access and encourage SME participation.

If systematically addressed, India could become a global nutraceutical leader, not just a fast-growing local market.

Conclusion

The Indian nutraceutical sector’s growth narrative is compelling, backed by strong demand and significant investment projections. However, regulatory clarity, quality assurance, and inclusive pricing remain pivotal challenges. Data indicates that tackling these issues — through policy, science, and consumer education — will determine whether India evolves from a growth story to a trusted global nutraceutical powerhouse.

Frequently Asked Questions (FAQs)

1. What is the current size of the Indian nutraceutical industry?

India’s nutraceutical market is estimated at ~USD 30 billion (2024) and projected to reach USD 60–65 billion by 2030, growing at a CAGR of approximately 13–15%. Growth is driven by preventive healthcare awareness, rising lifestyle diseases, and digital commerce penetration.

2. Who regulates nutraceuticals in India?

Nutraceuticals in India are regulated by the Food Safety and Standards Authority of India (FSSAI) under the Food Safety and Standards Act, 2006.

They fall under:

• Health Supplements
• Nutraceuticals
• Functional Foods
• Foods for Special Dietary Use (FSDU)

Unlike pharmaceuticals, they are regulated as food products, not drugs.

3. What are the biggest problems in the Indian nutraceutical industry?

Major challenges include:

• Regulatory ambiguity (food vs drug classification confusion)
• Inconsistent state-level enforcement
• Quality control failures (mislabeling, contamination cases reported)
• High GST (18–28%) compared to essential food items
• Low clinical validation compared to global standards

These issues impact consumer trust and export competitiveness.

4. Are nutraceuticals safe in India?

Most licensed products are safe when manufactured under FSSAI guidelines. However:

• Some independent testing has shown non-compliance in labeling or ingredient levels.
• Consumers should look for:
  • FSSAI license number
  • GMP certification
  • Third-party testing
  • Transparent ingredient disclosure

Evidence-based brands investing in quality testing are generally more reliable.

5. Why is the Indian nutraceutical industry growing so fast?

Key drivers include:

• Rising prevalence of diabetes, obesity, and cardiovascular diseases
• Increased health awareness post-COVID
• Growth of e-commerce platforms
• Higher disposable income among urban middle class
• Preventive healthcare trend

India’s demographic dividend (young working population) is also fueling supplement demand.